Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|6|1|52-60

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.6, Iss.1, 2008-01, pp. : 52-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation

By Schrama Y.C.   van Dam T.   Fijnheer R.   Hene R.J.   de Groot P.   Rabelink T.J.  

The Netherlands Journal of Medicine, Vol. 59, Iss. 1, 2001-07 ,pp. : 6-15

Elsevier

Access to resources Recommend Favorite

EFFECT OF ISRADIPINE ON IN-VIVO PLATELET FUNCTION - I. Effect on progression of atherosclerosis and endothelial dysfunction

By O'Grady J.   Kritz H.   Schmid P.   Pirich C.   Sinzinger H.  

Thrombosis Research, Vol. 86, Iss. 5, 1997-06 ,pp. : 363-371

Elsevier

Access to resources Recommend Favorite

Platelet activation in subjects with impaired glucose tolerance

By Coban Erkan   Kucuktag S.   Basyigit S.  

Platelets, Vol. 18, Iss. 8, 2007-12 ,pp. : 591-594

Informa Healthcare

Access to resources Recommend Favorite

Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease

By Robinson S. D.   Harding S. A.   Cummins P.   Din J. N.   Sarma J.   Davidson I.   Fox K. A. A.   Boon N. A.   Newby D. E.  

Platelets, Vol. 17, Iss. 3, 2006-05 ,pp. : 158-162

Informa Healthcare

Access to resources Recommend Favorite

Circulating Markers of Endothelial Dysfunction and Platelet Activation in Patients with Severe Symptomatic Cerebral Small Vessel Disease

By  

Cerebrovascular Diseases, Vol. 36, Iss. 2, 2013-09 ,pp. : 131-138

Karger

Access to resources Recommend Favorite